Market Cap 29.49M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 314,008
Avg Vol 139,788
Day's Range N/A - N/A
Shares Out 8.70M
Stochastic %K 53%
Beta 1.14
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
dlev18
dlev18 Aug. 19 at 8:40 PM
$BCTX people think we’re a bitcoin stock or are we actually showing momentum???
0 · Reply
durocali
durocali Aug. 19 at 7:58 PM
$BCTX lucky to be able to add @ $3.40 this week. market may sense a bit more validation around the potential for Bria-IMT favorable topline data to come this 2H2026... with nice sympathy move up today on heels of $MRK and $MRNA news. countdown to readout ticking louder...
0 · Reply
rp6577
rp6577 Aug. 19 at 7:20 PM
$BCTX heating up $XBI
0 · Reply
Stonehands
Stonehands Aug. 19 at 7:18 PM
$BCTX hmmm
0 · Reply
tbagoni
tbagoni Aug. 19 at 7:13 PM
0 · Reply
tname
tname Aug. 19 at 7:11 PM
$BCTX 🚀
0 · Reply
Kirubin
Kirubin Aug. 19 at 7:01 PM
$BCTX okay! Started with 11K this morning! Just to nibble at it! Gamble gable! Price has stabilized! sell order at $120🫢🤦🏽‍♂️
2 · Reply
smallpower17
smallpower17 Aug. 19 at 6:31 PM
$BCTX Since there are no good other options for metastatic breast cancer, the other options have horrible side effects, the BriaCell therapy has shown no side effects, and the Phase 3 trial results will be categorized into several different patient subgroups, there are several paths for full approval (each of the patient subgroups - patients with intracranial disease, as just one example).
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 19 at 4:56 PM
$BCTX wake me up at $300
1 · Reply
rp6577
rp6577 Aug. 19 at 4:37 PM
$BCTX looking for that $4 break
1 · Reply
Latest News on BCTX
BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site

2026-07-16T13:27:49.000Z - 4 weeks ago

BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site


BriaCell announces Odette Cancer Centre joins Bria-IMT trial

2026-07-16T11:40:48.000Z - 4 weeks ago

BriaCell announces Odette Cancer Centre joins Bria-IMT trial


BriaCell enters MoU with Uneedle for microneedle technology

2026-06-25T11:45:30.000Z - 7 weeks ago

BriaCell enters MoU with Uneedle for microneedle technology


BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Closing of Offering


BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 2 months ago

BriaCell Presents Positive Clinical Data at ASCO 2026


BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Pricing of Offering


BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 3 months ago

BriaCell announces data from Bria-IMT at ASCO 2026


BriaCell adds Penn Medicine as Phase 3 breast cancer study site

2026-05-13T14:41:55.000Z - 3 months ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site


BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients


BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 3 months ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial


BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 4 months ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026


BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T13:28:43.000Z - 4 months ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting


BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 4 months ago

BriaCell presents anti-cancer activity of Bria-OTS


BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 5 months ago

BriaCell to present four posters at the 2026 AACR


BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 5 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting


BriaCell Therapeutics trading resumes

2026-01-13T14:41:11.000Z - 7 months ago

BriaCell Therapeutics trading resumes


BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:35:29.000Z - 7 months ago

BriaCell Therapeutics trading halted, volatility trading pause


BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 10 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


dlev18
dlev18 Aug. 19 at 8:40 PM
$BCTX people think we’re a bitcoin stock or are we actually showing momentum???
0 · Reply
durocali
durocali Aug. 19 at 7:58 PM
$BCTX lucky to be able to add @ $3.40 this week. market may sense a bit more validation around the potential for Bria-IMT favorable topline data to come this 2H2026... with nice sympathy move up today on heels of $MRK and $MRNA news. countdown to readout ticking louder...
0 · Reply
rp6577
rp6577 Aug. 19 at 7:20 PM
$BCTX heating up $XBI
0 · Reply
Stonehands
Stonehands Aug. 19 at 7:18 PM
$BCTX hmmm
0 · Reply
tbagoni
tbagoni Aug. 19 at 7:13 PM
0 · Reply
tname
tname Aug. 19 at 7:11 PM
$BCTX 🚀
0 · Reply
Kirubin
Kirubin Aug. 19 at 7:01 PM
$BCTX okay! Started with 11K this morning! Just to nibble at it! Gamble gable! Price has stabilized! sell order at $120🫢🤦🏽‍♂️
2 · Reply
smallpower17
smallpower17 Aug. 19 at 6:31 PM
$BCTX Since there are no good other options for metastatic breast cancer, the other options have horrible side effects, the BriaCell therapy has shown no side effects, and the Phase 3 trial results will be categorized into several different patient subgroups, there are several paths for full approval (each of the patient subgroups - patients with intracranial disease, as just one example).
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 19 at 4:56 PM
$BCTX wake me up at $300
1 · Reply
rp6577
rp6577 Aug. 19 at 4:37 PM
$BCTX looking for that $4 break
1 · Reply
AliceFireSteam
AliceFireSteam Aug. 19 at 2:44 PM
$BCTX Merck and Moderna have just released data on a cancer vaccine. Personalized patient-by-patient Cpi+Intismeran, slow, expensive but it works, only helps to prove the Briacell method. Bristol Myers Squibb, 11B in the vault, with no current competition against this vaccine... Buyout probably?
2 · Reply
jfun1
jfun1 Aug. 19 at 2:29 PM
$BCTX Definitely eyes on the vaccines for cancer treatments. Great for humanity if they work
0 · Reply
Kirubin
Kirubin Aug. 19 at 2:08 PM
$BCTX okay🫡🫢
0 · Reply
letsdodiz
letsdodiz Aug. 19 at 2:01 PM
$BCTX volume is picking up . Looks like we are getting some vibes from Moderna news. I bought some Moderna in the 20s and sold in the 50s.🥲
1 · Reply
Ares77manoe
Ares77manoe Aug. 19 at 1:57 PM
$BCTX nice
0 · Reply
AliceFireSteam
AliceFireSteam Aug. 19 at 4:12 AM
$BCTX https://www.researchgate.net/scientific-contributions/William-Williams-2142334235 for those that want the underlying data (paid)
1 · Reply
USAEquityResearch
USAEquityResearch Aug. 19 at 12:03 AM
$BCTX 📊 USAEquityResearch ▲ 3.53 (+4.13%) Trend: Bullish 📈 RSI (14): 52.0 — neutral territory MACD: bearish, below signal line Volume: below average 📌 Key Levels Resistance: 3.73 Support: 3.36 20-MA: 3.51 | 50-MA: 3.34 Educational content only. Not financial advice.
0 · Reply
NoFooling
NoFooling Aug. 18 at 6:49 PM
$BCTX watch RENMARK PRESENTATION of June 25, 2026 especially the Q&A: Best case scenario is 144th death occurs in December = Survival Readout exceeds anticipated successful June Conclusion by 6 months. https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-06-25-11-00-00/index.html
3 · Reply
smallpower17
smallpower17 Aug. 18 at 5:08 PM
$BCTX Rumors of great trial results leaking out??
1 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:46 PM
0 · Reply
AliceFireSteam
AliceFireSteam Aug. 17 at 9:25 AM
$BCTX per the sec filling of the last offering with ThinkEquity they are blocked from new offerings until September.
0 · Reply
BHWinehouse
BHWinehouse Aug. 16 at 8:28 PM
$BCTX Fun fact: Our CRO, Prevail InfoWorks, not only is our CRO but, at the time, also "saw something" that compelled them to invest in BCTX via their investment arm Prevail Partners at a 20% premium.
0 · Reply